Resonex opts out of direct U.S. sales, focuses on growing foreign MR business

Article

MRI supplier Resonex reported last week that it has ceased directsales and marketing operations in North America, choosing insteadto build on its growing business in China, other Asia/Pacificmarkets and Latin America. The Fremont, CA, firm is talking

MRI supplier Resonex reported last week that it has ceased directsales and marketing operations in North America, choosing insteadto build on its growing business in China, other Asia/Pacificmarkets and Latin America. The Fremont, CA, firm is talking withseveral companies--including an unnamed major medical imagingvendor--about the sale of manufacturing and distribution rightsfor its resistive MRI equipment in the U.S.

As of the December meeting of the Radiological Society of NorthAmerica, Resonex had hoped to counter depressed U.S. MRI marketconditions with a niche orthopedic imaging strategy. The MRI-onlyfirm had flat sales last year, but only because of a strong burstin its international business that balanced a U.S. decline, accordingto Gerald D. Knudson, president and CEO.

Resonex booked a 10-system order through its Chinese distributorin 1993, of which five units were shipped last year, he told SCAN.An additional China contract was under negotiation for 1994.

The U.S. firm anticipates opening a Chinese office this yearto support its distribution efforts, Knudson said. Joint venturepossibilities are also under consideration.

"It would be to our advantage to establish an early-stagemanufacturing/assembly program for China," he said.

Resonex's decision to focus on China and other emerging MRImarkets reflects a consensus within the industry that Asia/Pacificwill become the dominant region for MRI sales moving into thenext century.

The vendor's retreat in the U.S. indicates that intensifyingprice and technological competition among the giant multimodalityimaging manufacturers finally proved too much for one of the fewsmall, dedicated MRI suppliers in the market. Service and applicationsorganizations will remain in place for support of U.S. installationsand upgrades will continue to be offered, the company said.

Resonex has about 65 Paradigm and older Rx 4000 systems installed worldwide. Of these, 80% are functioning in the U.S., Knudsonsaid. Apart from China, the vendor has obtained orders in LatinAmerica, Eastern Europe and the Middle East.

The Resonex vertical-field, resistive MR technology has somesiting advantages over superconductive systems, which is relevantin markets with developing infrastructures. The scanners can shutdown and restart quickly when necessary. No ramping up is required.In addition, Paradigm can be taken apart into four pieces forease of transportation and installation, he said.

"(Developing markets) are ideal for this system, primarilybecause of its ease of siting," Knudson said. "It isa robust system."

Resonex developed a U.S. medical advisory board last year comprisingorthopedic surgeons and orthopedic radiologists, and was coordinatingthe establishment of what it labeled "a network of orthopediccenters of excellence" throughout the U.S.

The vendor's RSNA product highlights over the past two yearshave focused on positioning devices and other technology to providequantitative and repeatable MRI information for orthopedists.International sales, on the other hand, were aimed at brain andother general MR imaging applications.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.